Walgreens' Q2 2025 earnings report

Walgreens Boots Alliance Q1 Earnings Beat with $0.51 EPS and $39.46B Revenue, Stock Surges

Jan 10, 2025, 12:28 PM

Walgreens Boots Alliance Inc. reported its fiscal 2025 first-quarter earnings, surpassing Wall Street's expectations. The company achieved an adjusted earnings per share of $0.51, beating the estimate of $0.37, and generated revenue of $39.46 billion, exceeding the expected $37.36 billion, marking a 7.5% year-over-year growth. Despite a net loss of $265 million for the quarter, primarily due to higher operating losses from its multiyear plan to close underperforming stores, Walgreens maintained its fiscal 2025 adjusted earnings guidance of $1.40 to $1.80 per share. The company did not provide an annual sales outlook in its release. Walgreens' stock surged over 5% in premarket trading following the earnings announcement. The company's three business segments all reported growth, with U.S. retail pharmacy sales reaching $30.87 billion, up 6.6% year-over-year, U.S. healthcare sales at $2.17 billion, up 12.5% year-over-year, and international sales at $6.43 billion, up 10.2% year-over-year. CEO Tim Wentworth highlighted the company's focus on stabilizing the retail pharmacy by optimizing its footprint and controlling operating costs as part of its turnaround strategy.